Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epstein Barr Virus Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04191187
What this trial is testing

Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBiphenotypic Acute Leukemia+15 more
H. Lee Moffitt Cancer Center and Research Institute 34
Early research (Phase 1)UnknownNCT06056752
What this trial is testing

QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Anhui Provincial Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00003143
What this trial is testing

Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 20
Not applicableUnknownNCT01972815
What this trial is testing

Reproducibility and Reliability of Epstein-Barr Virus (EBV) DNA/RNA Measures in Nasopharyngeal Swabs

Who this might be right for
Suspect NPC PatientsNPC Multiplex Families
National Taiwan University Hospital 100
Early research (Phase 1)Study completedNCT03751709
What this trial is testing

Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL

Who this might be right for
B-Cell Acute Lymphoblastic LeukaemiaALL, AdultB-ALL
Cedars-Sinai Medical Center 22
Testing effectiveness (Phase 2)Study completedNCT00474929
What this trial is testing

Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 103
Early research (Phase 1)Looking for participantsNCT04260022
What this trial is testing

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Who this might be right for
Leukemia, Myeloid, ChronicMyeloid LeukemiaChronic Myeloid Leukemia+2 more
Ascentage Pharma Group Inc. 242
Early research (Phase 1)Study completedNCT02568553
What this trial is testing

Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Burkitt LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+23 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT01139970
What this trial is testing

Veliparib and Temozolomide in Treating Patients With Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome+13 more
National Cancer Institute (NCI) 66
Not applicableStudy completedNCT02335437
What this trial is testing

Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents

Who this might be right for
Fatigue Syndrome, ChronicEpstein-Barr Virus Infections
University Hospital, Akershus 270
Large-scale testing (Phase 3)Study completedNCT00799461
What this trial is testing

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Testing effectiveness (Phase 2)Looking for participantsNCT07306156
What this trial is testing

GP350 CAR-T for Relapse/Refractory and Epstein-Barr Virus Infection Associated Lymphoid Neoplasms

Who this might be right for
EBV Associated Lymphoid Neoplasms
Zhimin Zhai 24
Testing effectiveness (Phase 2)Study completedNCT00003245
What this trial is testing

Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 50
Not applicableNot Yet RecruitingNCT06131489
What this trial is testing

Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement

Who this might be right for
Hemophagocytic LymphohistiocytosisEpstein-Barr VirusBowel Resection
Beijing Friendship Hospital 20
Not applicableUnknownNCT05225493
What this trial is testing

HIV Indicator Diseases in Hospital and Primary Care

Who this might be right for
HIV InfectionsPrimary Health CareAcquired Immunodeficiency Syndrome+15 more
Erasmus Medical Center 1,500
Not applicableEnded earlyNCT00253552
What this trial is testing

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
OHSU Knight Cancer Institute 4
Early research (Phase 1)Active Not RecruitingNCT02879695
What this trial is testing

Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia

Who this might be right for
Recurrent B Acute Lymphoblastic LeukemiaRecurrent Mixed Phenotype Acute LeukemiaRefractory B Acute Lymphoblastic Leukemia+1 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Early research (Phase 1)Active Not RecruitingNCT05270057
What this trial is testing

Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies

Who this might be right for
B-cell LymphomaBurkitt Lymphoma
Medical College of Wisconsin 11
Not applicableStudy completedNCT01744587
What this trial is testing

Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients

Who this might be right for
NPC
National Health Research Institutes, Taiwan 353
Next Page